A Better Way Forward for Cancer Treatment

Dr. Powderly’s research on early phase immunotherapy research has led to over 100 publications, including those in the New England Journal of Medicine, Journal of Clinical Oncology, Journal of Immunotherapy, Nature, Clinical Cancer Research, Clinical Chemistry, Investigational New Drugs, and Science Translational Medicine. He is also a reviewer for multiple cancer journals and NIH grants, and is currently adjunct Clinical Assistant Professor of Medicine at both Duke and UNC. In 2014 he was awarded the David King Community Scientist Award by the Association of Community Cancer Centers (ACCC) and the Charlotte Business Journal Family Business Award in 2019. Many of his articles and presentations have been recognized as “top 50 most cited articles by JCO” and “top 10 most downloaded ASCO Video Presentations”, and was awareded the 2015 Herbert Pardes Clinical Research Excellence Award. In total, Dr. Powderly’s research has been cited over 4,500 times in published scientific literature.